Capital Fund Management »

Stoke Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $372k 12k 31.74

More positions owned by Capital Fund Management

Tesla Tesla Inc Com (TSLA)
Micron Technology Micron Technology Inc Com (MU)
Apple Apple Inc Com (AAPL)
Microsoft Corp Microsoft Corp Com (MSFT)
Taiwan Semiconductor Manufac Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Chevron Corporation Chevron Corporation Com (CVX)
Amazon Amazon Com Inc Com (AMZN)
Eli Lilly & Co Eli Lilly & Co Com (LLY)
Palantir Technologies Inc Cl A Palantir Technologies Inc Cl A (PLTR)
Citigroup Citigroup Inc Com New (C)
Berkshire Hathaway Inc Del Cl B Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ge Aerospace Ge Aerospace Com New (GE)
Meta Platforms Inc Cl A Meta Platforms Inc Cl A (META)
Advanced Micro Devices Advanced Micro Devices Inc Com (AMD)
Lam Research Corp Lam Research Corp Com New (LRCX)

View all positions for Capital Fund Management

Top funds holding Stoke Therapeutics

FMR
Rtw Investments
BlackRock
Lynx1 Capital Management
Redmile Group
Morgan Stanley
Baker Bros. Advisors
Toronto-Dominion Bank
Vanguard Group
BVF
State Street Corporation
Vanguard Capital Management
Siren
Deerfield Management Company
Henderson Group

View all funds holding Stoke Therapeutics